The Venture Codex Logo

The Venture Codex

Overview

Targeted cell-based immunotherapy for cancer treatment.

Total Raised

$4 M

Rounds

2

Links

Verticals

Biotechnology
Clinical Trials
Therapeutics

Investment History

  1. Grant

    Oct 2022

    $2M

  2. Equity

    Jan 2013

    $2M

Team

Lowell Tilzer

Chief Executive Officer

Catherine E Lucasey

Co-Founder

Gary Wood

Chief Scientific Officer & Co-Founder

Ted Oliphant

Senior Director of Manufacturing